Published in Virology on March 01, 1979
Interferon-induced proteins in human fibroblasts and development of the antiviral state. J Virol (1980) 1.12
Accumulation of newly synthesized mRNAs in response to human fibroblast (beta) interferon. Proc Natl Acad Sci U S A (1981) 1.10
The interferon renaissance: molecular aspects of induction and action. Microbiol Rev (1981) 0.89
5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA. Proc Natl Acad Sci U S A (1981) 0.89
Elongation mechanism and substrate specificity of 2',5'-oligoadenylate synthetase. Proc Natl Acad Sci U S A (1980) 0.88
Kinetics of decay in the expression of interferon-dependent mRNAs responsible for resistance to virus. Proc Natl Acad Sci U S A (1980) 0.85
Double-stranded RNA inhibits a phosphoprotein phosphatase present in interferon-treated cells. Proc Natl Acad Sci U S A (1980) 0.79
Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells. J Virol (2016) 0.75
Order of transcription of genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 7.61
Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci U S A (1995) 6.95
Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell (1992) 5.72
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A (1985) 3.93
Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA. Proc Natl Acad Sci U S A (1994) 3.13
Mapping and identification of the vaccinia virus thymidine kinase gene. J Virol (1982) 2.44
Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J Virol (1987) 2.41
Fine structure analysis and nucleotide sequence of the vaccinia virus thymidine kinase gene. Proc Natl Acad Sci U S A (1983) 2.35
Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. Proc Natl Acad Sci U S A (1998) 2.31
Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge. J Virol (1986) 2.18
Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol (1986) 2.13
The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles. Virology (1995) 2.06
Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J Virol (1972) 2.00
Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. J Virol (1987) 1.98
Transcriptional map for Newcastle disease virus. J Virol (1980) 1.90
Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment. Nature (1974) 1.86
Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors. Proc Natl Acad Sci U S A (1986) 1.85
Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J Gen Virol (1987) 1.82
Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development. J Virol (2001) 1.70
Synthesis and processing of Sindbis virus nonstructural proteins in vitro. Virology (1982) 1.68
Coding assignments of the five smaller mRNAs of Newcastle disease virus. J Virol (1982) 1.67
The structure of pariacoto virus reveals a dodecahedral cage of duplex RNA. Nat Struct Biol (2001) 1.64
Control of expression of the vaccinia virus thymidine kinase gene. J Virol (1981) 1.60
Transcription and translation of Newcastle disease virus mRNA's in vitro. J Virol (1978) 1.56
Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells. Eur J Biochem (1978) 1.54
Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: comparison with the mouse low molecular weight inhibitor. Proc Natl Acad Sci U S A (1978) 1.54
The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J Virol (1994) 1.52
Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation. J Virol (1989) 1.50
Cell-free synthesis of enzymatically active vaccinia virus thymidine kinase. Virology (1981) 1.47
Nonhomologous RNA recombination during negative-strand synthesis of flock house virus RNA. J Virol (1993) 1.45
Transcriptional mapping of vesicular stomatitis virus in vivo. J Virol (1977) 1.45
Induction of 2'5'-oligoadenylate synthetase activity and a new protein by chick interferon. Virology (1979) 1.41
High-frequency homologous recombination in vaccinia virus DNA. J Virol (1987) 1.39
Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice. J Virol (1987) 1.38
Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2008). Arch Virol (2009) 1.37
VSV RNA synthesis: how can you be positive? Cell (1981) 1.35
Cleavage of the N-terminal formylmethionine residue from a bacteriophage coat protein in vitro. J Mol Biol (1973) 1.33
Comparisons among the larger genome segments of six nodaviruses and their encoded RNA replicases. J Gen Virol (2001) 1.30
Primer sets developed to amplify conserved genes from filamentous ascomycetes are useful in differentiating fusarium species associated with conifers. Appl Environ Microbiol (1995) 1.29
Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response. J Virol (2000) 1.28
Characterization and construction of functional cDNA clones of Pariacoto virus, the first Alphanodavirus isolated outside Australasia. J Virol (2000) 1.22
Synthesis of polypeptides directed by the RNA of phage Q beta. Virology (1970) 1.22
Coupled transcription and translation in mammalian and avian cell-free systems. Virology (1978) 1.20
Stress mRNA metabolism in canavanine-treated chicken embryo cells. Mol Cell Biol (1984) 1.19
Replication of flock house virus RNAs from primary transcripts made in cells by RNA polymerase II. J Virol (1997) 1.14
Helper T cell recognition of respiratory syncytial virus in mice. J Gen Virol (1988) 1.14
Characterization and template properties of RNA dimers generated during flock house virus RNA replication. Virology (2001) 1.07
Inhibition of Protein Synthesis in Cell-Free Systems from Interferon-Treated, Infected Cells: Further Characterization and Effect of Formylmethionyl-tRNA(F). J Virol (1974) 1.02
Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A. J Virol (1990) 1.00
Translation of black beetle virus RNA and heterologous viral RNAs in cell-free lysates derived from Drosophila melanogaster. J Virol (1981) 1.00
Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha. J Interferon Res (1985) 0.97
Induction and maintenance of autonomous flock house virus RNA1 replication. J Virol (1999) 0.96
Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system. Virology (1990) 0.93
The translation of vaccinia virus messenger RNA in animal cell-free systems. FEBS Lett (1973) 0.92
DNA-directed expression of an animal virus RNA for replication-dependent colony formation in Saccharomyces cerevisiae. J Virol (2002) 0.91
Interferons: biochemical, cell growth inhibitory, and immunological effects. Prog Hematol (1981) 0.91
Effect of interferon pretreatment on coupled transcription and translation in cell-free extracts of primary chick embryo cells. Virology (1978) 0.91
Induction, purification, and properties of 2'5' oligoadenylate synthetase. Ann N Y Acad Sci (1980) 0.88
Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices. J Clin Psychiatry (2000) 0.88
Secondary structure and coding potential of the coat protein gene of bacteriophage MS2. Nat New Biol (1973) 0.87
Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration. J Interferon Res (1986) 0.84
ICTV in San Francisco: a report from the Plenary Session. Arch Virol (2005) 0.83
Synthesis of plant virus coat proteins in an animal cell-free system. Nat New Biol (1973) 0.83
Recovery of infectious pariacoto virus from cDNA clones and identification of susceptible cell lines. J Virol (2001) 0.82
Implications of secondary structure in messenger RNA. J Theor Biol (1972) 0.82
The dissociation of Escherichia coli ribosomes. Eur J Biochem (1973) 0.82
A polarity gradient in the expression of the replicase gene of RNA bacteriophage Q beta. J Mol Biol (1973) 0.81
Cotranslational disassembly of flock house virus in a cell-free system. J Virol (1997) 0.81
Synthesis of vaccinia virus thymidine kinase in microinjected Xenopus oocytes. Virology (1982) 0.81
Comparative validity of seven scoring systems for the instrumental activities of daily living scale in rural elders. Aging Ment Health (2006) 0.80
Differential influence of safe versus threatening facial expressions on decision-making during an inhibitory control task in adolescence and adulthood. Dev Sci (2014) 0.80
Definition and functional analysis of the signal/anchor domain of the human respiratory syncytial virus glycoprotein G. J Gen Virol (1996) 0.79
Expression and glycosylation of the respiratory syncytial virus G protein in Saccharomyces cerevisiae. Virology (1987) 0.79
2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatment. Prog Clin Biol Res (1985) 0.79
Preliminary x-ray characterization of authentic providence virus and attempts to express its coat protein gene in recombinant baculovirus. Arch Virol (2005) 0.79
Silk gland-specific tRNA(Ala) genes interact more weakly than constitutive tRNA(Ala) genes with silkworm TFIIIB and polymerase III fractions. Mol Cell Biol (1994) 0.79
Mutual influence of the secondary structure and information content of a messenger RNA. J Theor Biol (1973) 0.78
Induction and maintenance of 2',5'-oligoadenylate synthetase in interferon-treated chicken embryo cells. Mol Cell Biol (1982) 0.76
Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans. J Clin Oncol (1984) 0.76
CALIFORNIA SOCIAL HYGIENE SOCIETY. Cal State J Med (1915) 0.75
Molecular mechanisms of interferon action. Med Pediatr Oncol (1981) 0.75
Techniques for the cell-free translation of viral RNA. Lab Res Methods Biol Med (1982) 0.75
Hanford-derived plutonium in columbia river sediments. Science (1981) 0.75
How to fine-tune your hiring process. J Clin Orthod (1989) 0.75
Codon base randomness in bacteriophage MS2. Nat New Biol (1973) 0.75
2',5'-oligoadenylate synthetase in interferon-treated chick cells. Tex Rep Biol Med (1983) 0.75
Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration. J Interferon Res (1992) 0.75